tiprankstipranks
Pediatrix Medical Group, Inc. (CH:PDC)
NYSE:PDC
Switzerland Market
PDC
Pediatrix Medical Group
RESEARCH TOOLSreports

Pediatrix Medical Group (PDC) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

PDC Analyst Ratings

Moderate Buy
5Ratings
Moderate Buy
2 Buy
3 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Pediatrix
Medical Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PDC Stock 12 Month Forecast

Average Price Target

$19.14
Based on 5 Wall Street analysts offering 12 month price targets for Pediatrix Medical Group in the last 3 months. The average price target is $19.14 with a high forecast of $21.35 and a low forecast of $17.40. The average price target represents a ― change from the last price of ―.
eyJuYXZpZ2F0b3IiOnsiZGlzYWJsZWQiOnRydWV9LCJleHBvcnRpbmciOnsiZW5hYmxlZCI6ZmFsc2V9LCJ0aXRsZSI6eyJ0ZXh0IjpudWxsfSwiY2hhcnQiOnsiaGVpZ2h0IjoyMDAsInN0eWxlIjp7ImZvbnRGYW1pbHkiOiJSb2JvdG8gRmxleCwgLWFwcGxlLXN5c3RlbSwgQmxpbmtNYWNTeXN0ZW1Gb250LCBTZWdvZSBVSSwgUm9ib3RvLCBIZWx2ZXRpY2EsIEFyaWFsLCBzYW5zLXNlcmlmLCBBcHBsZSBDb2xvciBFbW9qaSwgU2Vnb2UgVUkgRW1vamksIFNlZ29lIFVJIFN5bWJvbCIsImZvbnRXZWlnaHQiOiI0MDAiLCJjb2xvciI6IiM1ZDVkNWUifX0sInlBeGlzIjp7ImxhYmVscyI6eyJzdHlsZSI6eyJjb2xvciI6ImluaGVyaXQifX0sInZpc2libGUiOmZhbHNlfSwicGxvdE9wdGlvbnMiOnsic2VyaWVzIjp7InN0YXRlcyI6eyJpbmFjdGl2ZSI6eyJvcGFjaXR5IjoxfX19fSwieEF4aXMiOnsibGFiZWxzIjp7InN0eWxlIjp7ImNvbG9yIjoiaW5oZXJpdCJ9fSwidmlzaWJsZSI6ZmFsc2V9LCJsZWdlbmQiOnsic3ltYm9sUmFkaXVzIjowLCJzeW1ib2xQYWRkaW5nIjo0LCJzeW1ib2xIZWlnaHQiOjE0LCJib3JkZXJXaWR0aCI6MCwic3ltYm9sV2lkdGgiOjE0LCJhbGlnbiI6ImxlZnQiLCJ2ZXJ0aWNhbEFsaWduIjoiYm90dG9tIiwiZW5hYmxlZCI6ZmFsc2V9LCJ0b29sdGlwIjp7ImJhY2tncm91bmRDb2xvciI6IndoaXRlIn0sImNyZWRpdHMiOnsiZW5hYmxlZCI6ZmFsc2V9LCJhY2Nlc3NpYmlsaXR5Ijp7ImRlc2NyaXB0aW9uIjoiIn0sInNlcmllcyI6W3sidHlwZSI6ImFyZWEiLCJkYXRhIjpbXX1dfQ==
Highest Price Target$21.35Average Price Target$19.14Lowest Price Target$17.40
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on CH:PDC
A.J. Rice
UBS
UBS
CHF17.4→CHF19.77
Hold
―
Reiterated
05/12/26
Pediatrix Medical price target raised to $25 from $22 at UBSPediatrix Medical price target raised to $25 from $22 at UBS
Mizuho Securities Analyst forecast on CH:PDC
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF16.61→CHF18.98
Hold
―
Reiterated
05/08/26
Pediatrix Medical price target raised to $24 from $21 at MizuhoPediatrix Medical price target raised to $24 from $21 at Mizuho
Truist Financial Analyst forecast on CH:PDC
David S Macdonald
Truist Financial
Truist Financial
CHF18.19
Hold
―
Reiterated
05/06/26
Truist Financial Sticks to Their Hold Rating for Pediatrix Medical Group (MD)
William Blair Analyst forecast on CH:PDC
Ryan Daniels
William Blair
William Blair
CHF17.4
Buy
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO), Vertex Pharmaceuticals (NASDAQ: VRTX) and Pediatrix Medical Group (NYSE: MD)
Jefferies Analyst forecast on CH:PDC
Jack Slevin
Jefferies
Jefferies
CHF18.98→CHF21.35
Buy
―
Reiterated
04/20/26
Pediatrix Medical price target raised to $27 from $24 at JefferiesPediatrix Medical price target raised to $27 from $24 at Jefferies
Deutsche Bank Analyst forecast on CH:PDC
Pito Chickering
Deutsche Bank
Deutsche Bank
CHF16.61→CHF15.02
Hold
―
Reiterated
02/20/26
Pediatrix Medical price target lowered to $19 from $21 at Deutsche BankPediatrix Medical price target lowered to $19 from $21 at Deutsche Bank
Leerink Partners Analyst forecast on CH:PDC
Whit Mayo
Leerink Partners
Leerink Partners
CHF13.44
Hold
―
Reiterated
10/03/25
Leerink Partners Sticks to Their Hold Rating for Pediatrix Medical Group (MD)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on CH:PDC
A.J. Rice
UBS
UBS
CHF17.4→CHF19.77
Hold
―
Reiterated
05/12/26
Pediatrix Medical price target raised to $25 from $22 at UBSPediatrix Medical price target raised to $25 from $22 at UBS
Mizuho Securities Analyst forecast on CH:PDC
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF16.61→CHF18.98
Hold
―
Reiterated
05/08/26
Pediatrix Medical price target raised to $24 from $21 at MizuhoPediatrix Medical price target raised to $24 from $21 at Mizuho
Truist Financial Analyst forecast on CH:PDC
David S Macdonald
Truist Financial
Truist Financial
CHF18.19
Hold
―
Reiterated
05/06/26
Truist Financial Sticks to Their Hold Rating for Pediatrix Medical Group (MD)
William Blair Analyst forecast on CH:PDC
Ryan Daniels
William Blair
William Blair
CHF17.4
Buy
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO), Vertex Pharmaceuticals (NASDAQ: VRTX) and Pediatrix Medical Group (NYSE: MD)
Jefferies Analyst forecast on CH:PDC
Jack Slevin
Jefferies
Jefferies
CHF18.98→CHF21.35
Buy
―
Reiterated
04/20/26
Pediatrix Medical price target raised to $27 from $24 at JefferiesPediatrix Medical price target raised to $27 from $24 at Jefferies
Deutsche Bank Analyst forecast on CH:PDC
Pito Chickering
Deutsche Bank
Deutsche Bank
CHF16.61→CHF15.02
Hold
―
Reiterated
02/20/26
Pediatrix Medical price target lowered to $19 from $21 at Deutsche BankPediatrix Medical price target lowered to $19 from $21 at Deutsche Bank
Leerink Partners Analyst forecast on CH:PDC
Whit Mayo
Leerink Partners
Leerink Partners
CHF13.44
Hold
―
Reiterated
10/03/25
Leerink Partners Sticks to Their Hold Rating for Pediatrix Medical Group (MD)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Pediatrix Medical Group

3 Months
Ryan DanielsWilliam Blair
Success Rate
3/6 ratings generated profit
50%
Average Return
+12.87%
Copying Ryan Daniels's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +12.87% per trade.
1 Year
Ryan DanielsWilliam Blair
Success Rate
5/6 ratings generated profit
83%
Average Return
+20.17%
Copying Ryan Daniels's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +20.17% per trade.
2 Years
Ryan DanielsWilliam Blair
Success Rate
5/6 ratings generated profit
83%
Average Return
+15.37%
Copying Ryan Daniels's trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +15.37% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PDC Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
1
1
2
2
2
Hold
4
4
5
4
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
7
6
6
In the current month, PDC has received 2 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. PDC average Analyst price target in the past 3 months is 19.14.
Each month's total comprises the sum of three months' worth of ratings.

PDC Financial Forecast

PDC Earnings Forecast

Next quarter’s earnings estimate for PDC is $0.47 with a range of $0.45 to $0.49. The previous quarter’s EPS was $0.35. PDC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year PDC has Performed in-line its overall industry.
Next quarter’s earnings estimate for PDC is $0.47 with a range of $0.45 to $0.49. The previous quarter’s EPS was $0.35. PDC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year PDC has Performed in-line its overall industry.

PDC Sales Forecast

Next quarter’s sales forecast for PDC is $377.66M with a range of $370.79M to $381.39M. The previous quarter’s sales results were $375.86M. PDC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year PDC has Performed in-line its overall industry.
Next quarter’s sales forecast for PDC is $377.66M with a range of $370.79M to $381.39M. The previous quarter’s sales results were $375.86M. PDC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year PDC has Performed in-line its overall industry.

PDC Stock Forecast FAQ

What is CH:PDC’s average 12-month price target, according to analysts?
Based on analyst ratings, Pediatrix Medical Group, Inc.’s 12-month average price target is 19.14.
    What is CH:PDC’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:PDC, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Pediatrix Medical Group, Inc. a Buy, Sell or Hold?
        Pediatrix Medical Group, Inc. has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Pediatrix Medical Group, Inc.’s share price target?
          The average share price target for Pediatrix Medical Group, Inc. is 19.14. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $21.35 ,and the lowest forecast is $17.40. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Pediatrix Medical Group, Inc.?
            Pediatrix Medical Group, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
              How can I buy shares of Pediatrix Medical Group, Inc.?
              To buy shares of CH:PDC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.